CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4+Foxp3+ T and IL-17+CD4+ Th17 cells
Adoptive Cell Transfer
CCL5
Viral encephalitis
DOI:
10.1186/s12974-016-0656-x
Publication Date:
2016-07-20T10:02:02Z
AUTHORS (9)
ABSTRACT
CCR5 is a CC chemokine receptor involved in the migration of effector leukocytes including macrophages, NK, and T cells into inflamed tissues. Also, role CD4+Foxp3+ regulatory cell (Treg) homing has recently begun to grab attention. Japanese encephalitis (JE) defined as severe neuroinflammation central nervous system (CNS) following infection with mosquito-borne flavivirus JE virus. However, potential contribution progression via mediating Treg not been investigated. Infected wild-type (Ccr5+/+) CCR5-deficient (Ccr5−/−) mice were examined daily for mortality clinical signs, CNS was evaluated by infiltration inflammatory cytokine expression. In addition, viral burden, NK- JEV-specific responses analyzed. Adoptive transfer CCR5+CD4+Foxp3+ Tregs used evaluate progression. ablation exacerbated without altering burden extraneural tissues, manifested increased Ly-6Chi monocytes Ly-6Ghi granulocytes. Compared Ccr5+/+ mice, Ccr5−/− unexpectedly showed IFN-γ+NK CD8+ spleen, but CD4+ cells. More interestingly, CCR5-ablation resulted skewed response IL-17+CD4+ Th17 correspondingly reduced spleen brain, which closely associated JE. Our results also revealed that adoptive sorted could ameliorate apparently cells, myeloid-derived Instead, expression anti-inflammatory cytokines (IL-10 TGF-β) transferred CCR5+ found produce IL-10. regulates governing timely appropriate Tregs, thereby facilitating host survival. Therefore, this critical extended raises possible safety concerns regarding use antagonists human immunodeficiency virus (HIV)-infected individuals who inhabit regions both HIV flaviviruses, such JEV West Nile virus, are endemic.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (37)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....